Table 1 Factors associated with persistent swallowing disorders vs no or transient swallowing disorders
No or transient SD n = 124 (90%) | Persistent SD n = 14 (10%) | p | |
|---|---|---|---|
Male (n, (%)) | 73 (59) | 8 (57) | |
Age (years; mean ± SD) | 58 ± 15 | 66 ± 16 | 0.039 |
SAPS II at admission (mean ± SD) | 56 ± 21 | 58 ± 15 | 0.395 |
SOFA score at D1 (mean ± SD) | 9 ± 4 | 8 ± 4 | 0.283 |
Admission weight (kg; mean ± SD) | 87 ± 23 | 76 ± 15 | 0.033 |
Ratio patient size/tube diameter (mean ± SD) | 4.5 ± 0.3 | 4.5 ± 0.2 | 0.701 |
Neuromuscular blocking agent (N; (%)) | 81 (66) | 5 (36) | 0.039 |
Duration of neuromuscular blocking agent (D; (mean ± SD) | 3 ± 3 | 1 ± 2 | 0.023 |
Steroids (N; (%)) | 34 (28) | 3 (21) | 0.144 |
Prokinetics during 48 h before extubation (N; (%)) | 7 (6) | 1 (7) | 0.588 |
Antacids during 48 h before extubation (N; (%)) | 44 (36) | 6 (43) | 0.770 |
Duration of ICU stay (D; mean ± SD) | 21 ± 11 | 28 ± 15 | 0.073 |
Duration of intubation (D; mean ± SD) | 14 ± 7 | 17 ± 10 | 0.253 |
Duration of NIV (D; mean ± SD) | 1 ± 4 | 1 ± 2 | 0.528 |
MRC Scale for Muscle Strength score at extubation (mean ± SD) | 43 ± 11 | 37 ± 10 | 0.057 |
XII cranial nerve injury at extubation (N; (%)) | 58 (47%) | 11 (79%) | 0.045 |